This report presents valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher’s team of industry experts.
France is the second largest pharmaceutical and medical device market, in terms of value, in Europe after Germany. The French pharmaceutical market increased from €53.69B in 2015 to €60.05B in 2019 at a Compound Annual Growth Rate (CAGR) of 2.84%. In terms of US Dollars, the market increased from $59.54B in 2013 to $67.25B in 2020 at a CAGR of 3.09%. It is forecast to reach about $82.02B in 2025. The changing demographics, chronic and lifestyle diseases, incentives for innovation, universal health coverage, and early access to innovative medicines are the main factors driving the growth of the French pharmaceutical market.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in France, and includes:
Reasons to Buy
This report will enhance your decision-making capability by allowing you to:
France is the second largest pharmaceutical and medical device market, in terms of value, in Europe after Germany. The French pharmaceutical market increased from €53.69B in 2015 to €60.05B in 2019 at a Compound Annual Growth Rate (CAGR) of 2.84%. In terms of US Dollars, the market increased from $59.54B in 2013 to $67.25B in 2020 at a CAGR of 3.09%. It is forecast to reach about $82.02B in 2025. The changing demographics, chronic and lifestyle diseases, incentives for innovation, universal health coverage, and early access to innovative medicines are the main factors driving the growth of the French pharmaceutical market.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in France, and includes:
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Bayer, Pfizer, Sanofi, Viatris, and Servier
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Roche Diagnostics, EssilorLuxottica, and Air Liquide
- An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the French healthcare market
Reasons to Buy
This report will enhance your decision-making capability by allowing you to:
- Develop business strategies by understanding the trends shaping and driving France’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact France’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
Table of Contents
1. Table of Contents
2. Executive Summary
3. Overview of Pharmaceutical Market
4. Overview of Medical Devices Market
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
6. Deal Analysis
7. HealthTech Landscape
8. Market Access
9. Country Healthcare Landscape
13 Appendix
List of Tables
List of Figures